In endometrial cancer, miR195 inhibits cell migration and invasion by targeting GPER and inhibiting the epithelial-mesenchymal transition; both GPER expression and the AKT/PI3K signaling pathway were found to be involved [170]. This evidence concerns the gene GPER1 and endometrial cancer.